Asedebart

阿塞德拜单抗

Report date: 2026/05/20 17:55:43

Base Information

Drug NameAsedebart
Drug Alias NameLu AG13909
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-Actin, gamma-enteric smooth muscle
TargetsActin, gamma-enteric smooth muscle
Therapy Area/IndicationsCushing SyndromeAdrenal Hyperplasia, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenPoland +[12] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesH. Lundbeck A/S
China Registration ClassN/A

Develop Information

Active CompaniesH. Lundbeck A/S
Inactive CompaniesN/A
Active IndicationsCushing SyndromeAdrenal Hyperplasia, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A